Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
FDA
Biotech
Gilead liver disease med still delivers ahead of FDA verdict
Three months after spending $4.3 billion on CymaBay for its primary biliary cholangitis med, Gilead Sciences has presented a fresh slice of data.
James Waldron
May 20, 2024 8:30am
Karius snares FDA breakthrough tag for infectious disease test
May 16, 2024 7:55am
FDA approves self-collection screening for HPV, cervical cancer
May 15, 2024 11:03am
FDA elevates catheter recalls from Boston Scientific, Route 92
May 14, 2024 12:15pm
FDA tells users to throw away Cue Health's home COVID tests
May 14, 2024 11:19am
Guardant preps for FDA review of colorectal cancer blood test
May 13, 2024 1:48pm